FDA Inspection 1002842 — Lucile Salter Packard Children's Hospital Stanford Medicine Fertility and Reproductive Health
The FDA completed an inspection of Lucile Salter Packard Children's Hospital Stanford Medicine Fertility and Reproductive Health on February 28, 2017 in Sunnyvale, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 28, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Sunnyvale, CA (United States)